Should you buy Agenus (Agen) stock in 2022?

In 2022, Agenus's revenue was $98.02 million, a decrease of -66.85% compared to the previous year's $295.67 million. Losses were -$220.29 million, 812.6% more than in 2021. According to 5 analysts, the average rating for AGEN stock is "Strong Buy." The 12-month stock price forecast is $8.12, which is an increase of 927.72% from the latest price.

Where is Agenus Inc Agen headquartered?

Agenus Inc. is headquartered in Lexington, Massachusetts. View Agenus Inc AGEN investment & stock information. Get the latest Agenus Inc AGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

What is the 12-month price forecast for Agenus (Agen)?

The 12-month stock price forecast is $8.12, which is an increase of 927.72% from the latest price. LEXINGTON, Mass.-- (BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that data from an ...

Is Agen trading at a 34% discount?

AGEN is trading at a 34% discount. Is it the right time to buy, sell, or hold? Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AGEN is a good fit for your portfolio.